HFS
TMO icon

Hantz Financial Services’s Thermo Fisher Scientific TMO Stock Holding History

Hantz Financial Services’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.3M Sell
24,610
-3,867
-14% -$1.86M 0.17% 79
2026
Q1 		$14M Buy
28,477
+5,880
+26% +$3.19M 0.21% 67
2025
Q4 		$13.1M Sell
22,597
-1,185
-5% -$670K 0.19% 84
2025
Q3 		$11.5M Sell
23,782
-41,075
-63% -$19.1M 0.17% 97
2025
Q2 		$26.3M Sell
64,857
-6,004
-8% -$2.51M 0.43% 46
2025
Q1 		$35.3M Buy
70,861
+319
+0.5% +$173K 0.62% 33
2024
Q4 		$36.7M Sell
70,542
-6,211
-8% -$3.41M 0.64% 32
2024
Q3 		$47.5M Buy
76,753
+1,046
+1% +$619K 0.84% 20
2024
Q2 		$41.9M Sell
75,707
-2,586
-3% -$1.48M 0.81% 22
2024
Q1 		$45.5M Buy
78,293
+21,453
+38% +$12M 0.89% 23
2023
Q4 		$30.2M Sell
56,840
-2,575
-4% -$1.25M 0.66% 32
2023
Q3 		$30.1M Buy
59,415
+864
+1% +$460K 0.76% 25
2023
Q2 		$30.5M Sell
58,551
-990
-2% -$534K 0.76% 25
2023
Q1 		$34.3M Buy
59,541
+714
+1% +$402K 0.94% 19
2022
Q4 		$32.4M Buy
58,827
+37,794
+180% +$20M 0.98% 17
2022
Q3 		$10.7M Sell
21,033
-269
-1% -$151K 0.37% 78
2022
Q2 		$11.6M Sell
21,302
-192
-0.9% -$106K 0.39% 73
2022
Q1 		$12.7M Sell
21,494
-725
-3% -$416K 0.37% 78
2021
Q4 		$14.8M Buy
22,219
+1,014
+5% +$633K 0.43% 65
2021
Q3 		$12.1M Buy
21,205
+1,712
+9% +$940K 0.4% 72
2021
Q2 		$9.83M Buy
19,493
+351
+2% +$166K 0.36% 74
2021
Q1 		$8.74M Sell
19,142
-193
-1% -$92.1K 0.36% 77
2020
Q4 		$9.01M Buy
19,335
+4
+0% +$1.88K 0.4% 64
2020
Q3 		$8.54M Sell
19,331
-577
-3% -$238K 0.44% 56
2020
Q2 		$7.21M Sell
19,908
-45
-0.2% -$15.1K 0.4% 61
2020
Q1 		$5.66M Buy
+19,953
New +$6.29M 0.39% 67

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Hantz Financial Services's TMO Position: Q2 2026 in Review

Hantz Financial Services reduced its Thermo Fisher Scientific (TMO) stake by 14% in Q2 2026, selling an estimated $1.86M and leaving 24,610 shares worth $12.3M. The position accounts for 0.17% of the portfolio, ranked #79.

Hantz Financial Services first reported a position in TMO in Q1 2020 and has held it in 26 quarters since. The position peaked at $47.5M in Q3 2024. 2,389 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Hantz Financial Services held 24,610 shares of Thermo Fisher Scientific worth $12.3M as of Q2 2026.
  • Hantz Financial Services sold 3,867 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.86M.
  • Thermo Fisher Scientific made up 0.17% of Hantz Financial Services's portfolio in Q2 2026, its #79 holding.
  • Hantz Financial Services first reported a position in Thermo Fisher Scientific in Q1 2020 and has held it in 26 quarters since.
  • Hantz Financial Services's Thermo Fisher Scientific position peaked at $47.5M in Q3 2024.
  • 2,389 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Hantz Financial Services's 13F filing for Q2 2026, filed 13 Aug 2026.